Literature DB >> 16166297

Magnetic resonance angiography visualization of abnormal tumor vasculature in genetically engineered mice.

Lauren M Brubaker1, Elizabeth Bullitt, Chaoying Yin, Terry Van Dyke, Weili Lin.   

Abstract

Previous research on the vasculature of tumor-bearing animals has focused upon the microvasculature. Magnetic resonance angiography (MRA) offers a noninvasive, complementary approach that provides information about larger vessels. Quantitative analysis of MRA images of spontaneous preclinical tumor models has not been previously reported. Eleven TgT121;p53+/- mice, which invariably develop choroid plexus carcinoma (CPC), and nine age-matched healthy controls were imaged using T1, T2, and a high-resolution three-dimensional time-of-flight MRA sequences at 3 T. Tumors and vessels were segmented to determine tumor volume and vascular attributes, including number of terminal branches, vessel count, and the average vessel radii of MRA-visible vessels within the tumor. Differences in the vasculature between tumor-bearing animals and healthy controls were analyzed statistically. Although the spatial resolution of MRA prohibits visualization of capillaries, a high density of intratumor blood vessels was visualized in CPC mice. A significant increase in terminal branch count and vessel count, but not average vessel radius, was observed in CPCs when compared with normal controls. Both terminal branch count and vessel count were highly correlated with tumor volume. This study represents the first MRA analysis of a spontaneous preclinical brain tumor model. Although the spatial resolution of MRA is less than histologic analysis, MRA-obtained vascular attributes provide useful information with full brain coverage. We show that consistent tumor vasculature properties can be determined by MRA. Such methods are critical for developing preclinical therapeutic testing and will help guide the development of human brain tumor analyses.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16166297      PMCID: PMC2430271          DOI: 10.1158/0008-5472.CAN-04-4355

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  27 in total

1.  Nonrigid registration using free-form deformations: application to breast MR images.

Authors:  D Rueckert; L I Sonoda; C Hayes; D L Hill; M O Leach; D J Hawkes
Journal:  IEEE Trans Med Imaging       Date:  1999-08       Impact factor: 10.048

2.  Initialization, noise, singularities, and scale in height ridge traversal for tubular object centerline extraction.

Authors:  Stephen R Aylward; Elizabeth Bullitt
Journal:  IEEE Trans Med Imaging       Date:  2002-02       Impact factor: 10.048

3.  High-grade gliomas and solitary metastases: differentiation by using perfusion and proton spectroscopic MR imaging.

Authors:  Meng Law; Soonmee Cha; Edmond A Knopp; Glyn Johnson; John Arnett; Andrew W Litt
Journal:  Radiology       Date:  2002-03       Impact factor: 11.105

4.  Initial stages of tumor cell-induced angiogenesis: evaluation via skin window chambers in rodent models.

Authors:  C Y Li; S Shan; Q Huang; R D Braun; J Lanzen; K Hu; P Lin; M W Dewhirst
Journal:  J Natl Cancer Inst       Date:  2000-01-19       Impact factor: 13.506

5.  Selective inactivation of p53 facilitates mouse epithelial tumor progression without chromosomal instability.

Authors:  X Lu; G Magrane; C Yin; D N Louis; J Gray; T Van Dyke
Journal:  Mol Cell Biol       Date:  2001-09       Impact factor: 4.272

6.  Assessment of the neovascular permeability in glioma xenografts by dynamic T(1) MRI with Gadomer-17.

Authors:  Marleen Verhoye; Boudewijn P J van der Sanden; Paul F J W Rijken; Hans P W Peters; Albert J Van der Kogel; Gilke Pée; Greetje Vanhoutte; Arend Heerschap; Annemie Van der Linden
Journal:  Magn Reson Med       Date:  2002-02       Impact factor: 4.668

7.  Angiogenesis and prostate cancer: identification of a molecular progression switch.

Authors:  W J Huss; C F Hanrahan; R J Barrios; J W Simons; N M Greenberg
Journal:  Cancer Res       Date:  2001-03-15       Impact factor: 12.701

8.  Perfusion MR imaging in gliomas: comparison with histologic tumor grade.

Authors:  S J Lee; J H Kim; Y M Kim; G K Lee; E J Lee; I S Park; J M Jung; K H Kang; T Shin
Journal:  Korean J Radiol       Date:  2001 Jan-Mar       Impact factor: 3.500

9.  VEGF-A has a critical, nonredundant role in angiogenic switching and pancreatic beta cell carcinogenesis.

Authors:  Masahiro Inoue; Jeffrey H Hager; Napoleone Ferrara; Hans-Peter Gerber; Douglas Hanahan
Journal:  Cancer Cell       Date:  2002-03       Impact factor: 31.743

10.  Using relative cerebral blood flow and volume to evaluate the histopathologic grade of cerebral gliomas: preliminary results.

Authors:  Ji Hoon Shin; Ho Kyu Lee; Byung Duk Kwun; Jin-Suh Kim; Weechang Kang; Choong Gon Choi; Dae Chul Suh
Journal:  AJR Am J Roentgenol       Date:  2002-09       Impact factor: 3.959

View more
  9 in total

1.  Blood oxygen level dependent angiography (BOLDangio) and its potential applications in cancer research.

Authors:  Kejia Cai; Adam Shore; Anup Singh; Mohammad Haris; Teruyuki Hiraki; Prianka Waghray; Damodar Reddy; Joel H Greenberg; Ravinder Reddy
Journal:  NMR Biomed       Date:  2012-02-02       Impact factor: 4.044

2.  Comparison of digital subtraction angiography, micro-computed tomography angiography and magnetic resonance angiography in the assessment of the cerebrovascular system in live mice.

Authors:  Giovanna Figueiredo; Carolin Brockmann; Hanne Boll; Melanie Heilmann; Sebastian J Schambach; Teresa Fiebig; Martin Kramer; Christoph Groden; Marc A Brockmann
Journal:  Clin Neuroradiol       Date:  2011-11-24       Impact factor: 3.649

3.  Pepsin pretreatment allows collagen IV immunostaining of blood vessels in adult mouse brain.

Authors:  Sonia Franciosi; Rita De Gasperi; Dara L Dickstein; Daniel F English; Anne B Rocher; William G M Janssen; Daniel Christoffel; Miguel A Gama Sosa; Patrick R Hof; Joseph D Buxbaum; Gregory A Elder
Journal:  J Neurosci Methods       Date:  2007-02-25       Impact factor: 2.390

4.  High-resolution magnetic resonance angiography in the mouse using a nanoparticle blood-pool contrast agent.

Authors:  Gabriel P Howles; Ketan B Ghaghada; Yi Qi; Srinivasan Mukundan; G Allan Johnson
Journal:  Magn Reson Med       Date:  2009-12       Impact factor: 4.668

Review 5.  Glioblastoma multiforme: an emerging paradigm of anti-VEGF therapy.

Authors:  David A Reardon; Patrick Y Wen; Annick Desjardins; Tracy T Batchelor; James J Vredenburgh
Journal:  Expert Opin Biol Ther       Date:  2008-04       Impact factor: 4.388

6.  Malignancy-associated vessel tortuosity: a computer-assisted, MR angiographic study of choroid plexus carcinoma in genetically engineered mice.

Authors:  E Bullitt; P A Wolthusen; L Brubaker; W Lin; D Zeng; T Van Dyke
Journal:  AJNR Am J Neuroradiol       Date:  2006-03       Impact factor: 3.825

Review 7.  The emerging role of anti-angiogenic therapy for malignant glioma.

Authors:  David A Reardon; Annick Desjardins; Jeremy N Rich; James J Vredenburgh
Journal:  Curr Treat Options Oncol       Date:  2008-02-07

8.  Three-dimensional imaging of the mouse neurovasculature with magnetic resonance microscopy.

Authors:  Arvind P Pathak; Eugene Kim; Jiangyang Zhang; Melina V Jones
Journal:  PLoS One       Date:  2011-07-27       Impact factor: 3.240

9.  Heterogeneity of tumor vasculature and antiangiogenic intervention: insights from MR angiography and DCE-MRI.

Authors:  Wenlian Zhu; Yoshinori Kato; Dmitri Artemov
Journal:  PLoS One       Date:  2014-01-23       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.